China Approves HIV Drug For COVID Patients

As a result of China’s transition away from a “zero COVID” policy of lockdowns and toward acceptance that the virus is now endemic, the HIV drug Azvudine has been approved for treating COVID patients.

China Approves HIV Drug For COVID Patients 1

According to Reuters, citing the National Medical Products Administration, China on Monday issued the go-ahead to repurpose a drug that is generally used to treat specific HIV-1 virus infections for “normal type” COVID infections.

Genuine Biotech’s drug, Azvudine, was approved to treat particular HIV infections in July 2021.

In a late-stage clinical trial, 40.4% of patients taking Azvudine showed improvement in symptoms seven days after first taking the drug, compared with 10.9% in the control group, Henan province-based Genuine Biotech said in a statement earlier this month, without providing detailed readings. -Reuters

The term “normal type” COVID refers to coronavirus infections that involve symptoms of pneumonia but have not yet progressed to a severe stage.

The licensing of the prescription is the latest development in China’s transition away from a “zero Covid” policy of lockdowns and toward acceptance that the virus is now endemic and that it may be treated with an AIDS drug.

The availability of effective COVID vaccines and treatments is crucial in laying the groundwork for China’s potential pivoting from its “dynamic COVID zero” policy, which aims to eliminate every outbreak – however small – and relies on mass testing and strict quarantining. -Reuters

China granted Pfizer’s oral Paxlovid treatment approval in February for people with mild-to-moderate COVID who are at a high risk of developing severe disease.

GreatGameIndia is being actively targeted by powerful forces who do not wish us to survive. Your contribution, however small help us keep afloat. We accept voluntary payment for the content available for free on this website via UPI, PayPal and Bitcoin.

Support GreatGameIndia


  1. Well that makes sense, since the SARS-COV2 has a HIV protein component in it’s genome which came from the US pharm company patent in 2015. Why do you think the US and China are using HIV drugs to treat the bio-weapon, because the bio-weapon and bio-weapon injection both are causing HIV in people.

Leave a Reply